Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.

[1]  A. Saykin,et al.  The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates , 2018, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[2]  L. Minasian,et al.  Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Samantha D. Outcalt,et al.  Metastatic breast cancer patients’ expectations and priorities for symptom improvement , 2018, Supportive Care in Cancer.

[4]  Adrienne Morgan,et al.  Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors , 2017, BMJ Open.

[5]  Theresa A. Koleck,et al.  Perceived cognitive function for breast cancer survivors: association of genetic and behaviorally related variables for inflammation , 2017, Supportive Care in Cancer.

[6]  C. Heckler,et al.  Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Bjordal,et al.  Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence , 2017, Acta oncologica.

[8]  M. Taljaard,et al.  National survey of family physicians to define functional decline in elderly patients with minor trauma , 2016, BMC Family Practice.

[9]  H. Cohen,et al.  Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research. , 2016, Journal of geriatric oncology.

[10]  P. Gehrman,et al.  A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. , 2016, Sleep medicine reviews.

[11]  A. Starkweather,et al.  The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study , 2016, Journal of Cancer Research and Clinical Oncology.

[12]  L. Carlson,et al.  The Comparative Impact of Mindfulness-Based Cancer Recovery (MBCR) and Cognitive Behavior Therapy for Insomnia (CBT-I) on Sleep and Mindfulness in Cancer Patients. , 2015, Explore.

[13]  A. Hickey,et al.  Psychological interventions for women with non-metastatic breast cancer. , 2015, The Cochrane database of systematic reviews.

[14]  G. Abrams,et al.  Associations Between Cytokine Genes and a Symptom Cluster of Pain, Fatigue, Sleep Disturbance, and Depression in Patients Prior to Breast Cancer Surgery , 2015, Biological research for nursing.

[15]  S. Chambers,et al.  A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer , 2015, Front. Oncol..

[16]  N. Dreyer,et al.  Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. , 2014, Breast.

[17]  Theresa A. Koleck,et al.  Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer. , 2014, Oncology nursing forum.

[18]  T. Numakawa,et al.  The Role of Brain-Derived Neurotrophic Factor in Comorbid Depression: Possible Linkage with Steroid Hormones, Cytokines, and Nutrition , 2014, Front. Psychiatry.

[19]  J. Savard,et al.  Longitudinal changes in clusters of cancer patients over an 18-month period. , 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[20]  H. Wildiers,et al.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Lisa G. Smith,et al.  Comparison of younger and older breast cancer survivors and age‐matched controls on specific and overall quality of life domains , 2014, Cancer.

[22]  Kathryn A. Lee,et al.  Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy , 2014, Cancer.

[23]  Carolyn M. Reilly,et al.  Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. , 2014, Journal of the National Cancer Institute.

[24]  A. Saykin,et al.  Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. Carvalho,et al.  Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials. , 2014, Cancer treatment reviews.

[26]  L. Carlson,et al.  A longitudinal analysis of symptom clusters in cancer patients and their sociodemographic predictors. , 2014, Journal of pain and symptom management.

[27]  Shelli R. Kesler,et al.  Prevalence, mechanisms, and management of cancer-related cognitive impairment , 2014, International review of psychiatry.

[28]  A. Starkweather,et al.  A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine. , 2013, Current pharmacogenomics and personalized medicine.

[29]  S. Ancoli-Israel,et al.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. , 2013, Journal of the National Cancer Institute.

[30]  Y. T. Cheung,et al.  Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients. , 2013, Journal of clinical epidemiology.

[31]  Jingwei Wu,et al.  Somatic symptoms in cancer patients trajectory over 12 months and impact on functional status and disability , 2013, Supportive Care in Cancer.

[32]  David Cella,et al.  A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment , 2013, Supportive Care in Cancer.

[33]  Hee-Ju Kim,et al.  Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients , 2012, Cancer nursing.

[34]  Andrew J. Saykin,et al.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study , 2010, Breast Cancer Research and Treatment.

[35]  C. Cleeland,et al.  Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy , 2010, Brain, Behavior, and Immunity.

[36]  D. Cella,et al.  Cancer-related fatigue: definitions and clinical subtypes. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[37]  M. Dodd,et al.  The effect of symptom clusters on functional status and quality of life in women with breast cancer. , 2010, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[38]  M. C. Engebjerg,et al.  Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study , 2010, Breast Cancer Research and Treatment.

[39]  J. Myers.  Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. , 2008, Oncology nursing forum.

[40]  Ron Dumont,et al.  Wechsler Memory Scale–Third Edition , 2008 .

[41]  J. Bower.  Behavioral symptoms in patients with breast cancer and survivors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  John D E Gabrieli,et al.  Healthy and pathological processes in adult development: new evidence from neuroimaging of the aging brain , 2005, Current opinion in neurology.

[43]  Yaakov Stern,et al.  Cognitive Decline and Literacy Among Ethnically Diverse Elders , 2005, Journal of geriatric psychiatry and neurology.

[44]  Linas A. Bieliauskas,et al.  Mayo's Older Americans Normative Studies: Age- and IQ-Adjusted Norms for the Trail-Making Test, the Stroop Test, and MAE Controlled Oral Word Association Test , 2005, The Clinical neuropsychologist.

[45]  David Cella,et al.  The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation , 2003, Health and quality of life outcomes.

[46]  A. Saykin,et al.  The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy , 2003, Psycho-oncology.

[47]  D. Rubin,et al.  Testing the number of components in a normal mixture , 2001 .

[48]  M. Sprangers,et al.  The challenge of response shift for quality-of-life-based clinical oncology research. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[49]  D S Tulsky,et al.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  L. George,et al.  OARS Methodology , 1985, Journal of the American Geriatrics Society.

[51]  T. Manini,et al.  Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers. , 2017, Journal of geriatric oncology.

[52]  S. Schagen,et al.  Cognitive complaints after breast cancer treatments: Examining the relationship with neuropsychological test performance , 2014 .

[53]  Hee-Ju Kim,et al.  Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis. , 2012, Oncology nursing forum.

[54]  David Wechsler,et al.  Wechsler Memory scale. , 2005 .